News
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...
Good morning, everyone. Damian Garde here, filling in for Ed Silverman on a day that marks the belated but not unwelcome return of warm weather here on Pharmalot’s satellite campus. Please find ...
GlaxoSmithKline says that two major clinical studies successfully tested a new two-drug treatment regimen to control the virus that causes AIDS.
In 2007, Pharmalot officially launched; a year later, as newspapers reeled from the financial crisis, Silverman took a buyout. The story could have ended there. But over the years, Silverman (and ...
Nonetheless, the Pharmalot campus is engulfed by a healthy amount of snow and still more is falling. This is a good time, then, to pick up a cup of stimulation and get busy foraging for ...
Good morning, everyone, and welcome to another busy day. As always, we have gathered a few tidbits to help you along. Here are some of the more interesting developments we have come across ...
Pharmalot -- Hardly surprising in the wake of the big merger last year (or was it an acquisition?). The drugmaker is about to consolidate office space and operations in New Jersey - Roseland, Union ...
Former Star-Ledger pharmaceuticals reporter Ed Silverman is considering reviving his blog, Pharmalot. He is now the legal owner of "Pharmalot.com" and is keeping the brand alive in the form of a ...
On Monday, Pharmalot's Ed Silverman shocked the pharmaceutical business by returning from vacation and announcing that his blog was no more. Over the past two years, Pharmalot grew into the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results